Market research
185750.KO Chong Kun Dang Pharmaceutical Corp
KO KRW Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 866B
- P/E ratio
- 10.81
- Analyst target
- 102857.14
- Dividend yield
- 0.7%
- Beta
- 0.24
Community
Investor discussion
1 comment
Sign in to join the 185750.KO discussion.
5 years, 6 months ago
Chong Kun Dang Pharmaceutical Corp is currently in a long term downtrend where the price is trading 18.1% below its 200 day moving average.
From a valuation standpoint, the stock is 86.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.2.
Chong Kun Dang Pharmaceutical Corp's total revenue rose by 13.1% to $337B since the same quarter in the previous year.
Its net income has dropped by 29.5% to $11B since the same quarter in the previous year.
Finally, its free cash flow grew by 66.8% to $17B since the same quarter in the previous year.
Based on the above factors, Chong Kun Dang Pharmaceutical Corp gets an overall score of 3/5.